Dearth of stimulant drugs hit US, FDA, DEA calls for offloading quotas
HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one.
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.